Sign in

CIK 0001228627

  • Non-accelerated filer
  • Smaller reporting company

Opus Genetics, Inc.

Sign in to watch
Ticker
IRD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
113516358
Phone
+1 984-884-6030
Business address
8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
Former names
Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,211,769
in 7 filings, $50K under 10b5-1 plans

Net −$3,211,769. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-04-20 Ainsworth Sean Director Grant or award +24,367 321,692
2026-01-01 Ainsworth Sean Director Grant or award +42,507 297,325
2025-08-25 Ainsworth Sean Director Grant or award +86,956 $1.15 $100K 254,818
2025-04-30 Ainsworth Sean Director Grant or award +79,504 167,862
2025-04-30 Ainsworth Sean Director Grant or award · Stock Option (Right to Buy) +79,592 79,592
2024-06-11 Ainsworth Sean Director Grant or award +41,143 88,358
2024-06-11 Ainsworth Sean Director Grant or award · Stock Option (Right to Buy) +35,181 35,181
2023-06-06 Ainsworth Sean Director Grant or award +10,976 47,215
2023-06-06 Ainsworth Sean Director Grant or award · Stock Option +9,639 9,639
2022-10-19 Ainsworth Sean Director Option exercise +1,574 $0.00 $0 41,239
2022-10-19 Ainsworth Sean Director Option exercise · Series B Warrant (right to buy) −1,574 0
2022-06-13 Ainsworth Sean Director Grant or award · Stock Option (right to buy) +20,000 20,000
2021-06-07 Ainsworth Sean Director Grant or award · Stock Option (right to buy) +20,000 20,000
2020-11-19 Ainsworth Sean Director Purchase +8,865 44,665
2020-11-19 Ainsworth Sean Director Purchase · Series A Warrant (right to buy) +13,394 13,394
2020-11-19 Ainsworth Sean Director Purchase · Series B Warrant (right to buy) +1,574 1,574
2020-11-11 Ainsworth Sean Director Grant or award · Stock Option (right to buy) +5,000 5,000
2020-11-05 Ainsworth Sean Director Grant or award +35,800 35,800
2020-11-05 Ainsworth Sean Director Grant or award · Stock Option (right to buy) +35,663 35,663
2020-11-05 Ainsworth Sean Director Grant or award · Stock Option (right to buy) +52,825 52,825

Page 1 of 1 · 20 trades